HS Icon Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test

382200 (Harmonized System 1992 for 6-digit)

 2019
World Trade
: $28.3B, Rnk 87 / 4648

2019
Top Exporter | Top Importer
: $7.97B | $3.76B, United States | United States

2019
Product Complexity
: 1.05, Rnk 713 / 4826

2018 - 2019
Export Growth (CAGR)
: 1.83%, Rnk 1172 / 4648

2018
Mean Tariff
: 3.43%, Rnk 5451 / 6538

 2019
Share of World Trade
: 0.16%, Rnk 87 / 4648

Overview:  This page contains the latest trade data of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test. In 2019, Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were the world's 87th most traded product, with a total trade of $28.3B. Between 2018 and 2019 the exports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test grew by 1.83%, from  $27.8B to $28.3B. Trade in Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test represent 0.16% of total world trade.

Exports: In 2019 the top exporters of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test  were United States ($7.97B), Germany ($4.33B), United Kingdom ($2.09B), Netherlands ($2.05B), and Singapore ($1.34B).

Imports: In 2019 the top importers of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($3.76B), Germany ($3.07B), China ($2.34B), Netherlands ($1.71B), and France ($1.37B).

Tariffs: In 2018 the average tariff for Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test was 3.43%, making it the 5451st lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test are Bermuda (25%), Pakistan (19.5%), Azerbaijan (14.4%), Algeria (12.2%), and Aruba (12%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking: Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test ranks 713th in the Product Complexity Index (PCI).

Description: Composite diagnostic reagents are diagnostic reagents that detect multiple analytes. Common types of composite diagnostic reagents are ELISA, Western blot, and immunohistochemistry. Laboratory reagents are the materials, chemicals, compounds, or substances used in the laboratory. Common types of laboratory reagents are agarose, sodium chloride, ammonium hydroxide, and hydrogen peroxide.

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2019): United States, $7.97B

Top Destination (2019): United States, $3.76B

Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test are the world's 87th most traded product.

In 2019, the top exporters of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($7.97B), Germany ($4.33B), United Kingdom ($2.09B), Netherlands ($2.05B), and Singapore ($1.34B).

In 2019, the top importers of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($3.76B), Germany ($3.07B), China ($2.34B), Netherlands ($1.71B), and France ($1.37B).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2018 -  2019): United States, $338M

Top Destination Growth (2018 - 2019): United States, $264M

Between 2018 and 2019, the exports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test grew the fastest in United States ($338M), Poland ($143M), Netherlands ($139M), Singapore ($134M), and Japan ($127M).

Between 2018 and 2019, the fastest growing importers of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($264M), China ($165M), Netherlands ($131M), United Kingdom ($99M), and Ireland ($34M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test.

In 2019,  market concentration measured using Shannon Entropy, was 3.9. This means that most of the exports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test are explained by 14 countries.

Explore Visualizations

TOP NET EXPORTER (2019): United States, $4.21B

TOP NET IMPORTER (2019): China, $1.8B

This map shows which countries export or import more of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test. Each country is colored based on the difference in exports and imports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test during 2019.

In 2019, the countries that had a largest trade value in exports than in imports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($4.21B), Germany ($1.25B), United Kingdom ($841M), Singapore ($794M), and Sweden ($572M).

In 2019, the countries that had a largest trade value in imports than in exports of Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were China ($1.8B), Italy ($603M), India ($349M), Saudi Arabia ($342M), and Brazil ($331M).

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test was 3.43%.  The countries with the highest tariffs for importing Composite diagnostic or laboratory reagents, including COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid test were Bermuda (25%), Pakistan (19.5%), Azerbaijan (14.4%), Algeria (12.2%), and Aruba (12%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.